Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients

Kidney Int. 2022 Jun;101(6):1282-1286.

Authors:

Al Jurdi A, Gassen RB, Borges TJ, Lape IT, Morena L, Efe O, Solhjou Z, El Fekih R, Deban C, Bohan B, Pattanayak V, Kotton CN, Azzi JR, Riella LV

Abstract:

The aim of this study was to evaluate antiviral humoral responses against SARS-CoV-2 variants, including the Delta and Omicron variants, following the third dose of SARS-CoV-2 mRNA vaccination in KTRs.

Download PDF here:

LVR_Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients KI 2022

Figure 2 | Poor anti–receptor binding domain (RBD) antibody and neutralization responses to the Omicron variant before and after the third dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine in kidney transplant recipients (KTRs).